Expert Columns by Sheela Ranganathan - O'Neill : O'Neill

Opinion & Analysis

November 20, 2024

Pharmaceutical Industry Seeks to Thwart State Initiatives to Tackle Unaffordability of Prescription Drugs

Opinion & Analysis

May 8, 2024

Threats to EMTALA: Unpacking the Oral Arguments in Idaho v. United States

Opinion & Analysis

March 7, 2024

No Surprises Act Litigation: Where We Are and What Comes Next

Opinion & Analysis

February 1, 2024

Unpacking Recent Antitrust Challenges to Private Equity in Health Care

Opinion & Analysis

November 20, 2023

Latest Development in Legal Challenges to Arbitration Process Under No Surprises Act

Sheela Ranganathan Former Associate

The Latest

Op-Ed

November 6, 2025

Sudan Is in Free Fall

Announcement

November 6, 2025

O’Neill Institute Health Law LL.M. Alumni Appointed Justice of the High Court of Ghana

Opinion & Analysis

November 6, 2025

Recent Developments in Orange Book Litigation: How Patent Disputes Shape Prescription Drug Affordability